Seres Therapeutics, Inc. (MCRB) Stock Investment Calculator & Historical Return Analysis
Seres Therapeutics is a commercial-stage biotechnology company focused on revolutionizing the treatment of a wide range of diseases by modulating the function of the human microbiome. Investors often view Seres Therapeutics, Inc. as a key player in the market, analyzing its long-term potential through various revenue models, brand recognition, and consistent presence in its industry.
This Seres Therapeutics, Inc. stock investment calculator allows you to explore how a hypothetical investment in MCRB might have performed over time. By adjusting the investment amount and time period, you can visualize potential growth, compare outcomes across different market cycles, and better understand the impact of long-term investing.
What if you invested $1000 in MCRB on Jan 1, 2020?
Explore hypothetical investment results for stocks, ETFs, and more. See real historical data and share your discoveries.
Understanding Seres Therapeutics, Inc.'s Historical Performance
Seres Therapeutics, Inc.'s stock performance has historically reflected both broader market trends and company-specific milestones. Like many growth-oriented stocks, MCRB has experienced periods of growth driven by innovation and market demand.
When analyzing Seres Therapeutics, Inc.'s historical returns, it's important to consider:
- Market cycles: Strong bull markets often amplify returns, while recessions can temporarily suppress performance.
- Business model evolution: Changes in revenue strategies and product lines can significantly impact stability.
- Long-term trends: Over extended periods, compounding can play a larger role than short-term price fluctuations. Try our calculator to explore returns over 5 years or larger investments over 10 years.
This calculator helps you see how these factors might have affected an investment depending on when you entered the market.
Historical Annual Returns
Over the past 11 years, Seres Therapeutics, Inc. has delivered an average annual return of 19.5%. The stock peaked in 2020 with a massive +631.3% gain, while investors faced a downturn in 2023 (-74.1%). Overall, the stock finished in the green 2 times out of 11 years.
Avg Return
+19.5%
Win Rate
18%
2W - 9L
Best
+631.3%
2020
Worst
-74.1%
2023
Performance Consistency
Seres Therapeutics, Inc. Annual Returns by Year
| Year | Annual Return | Start Price | End Price |
|---|---|---|---|
| 2015 | -31.73% | $1028.00 | $701.80 |
| 2016 | -70.97% | $682.00 | $198.00 |
| 2017 | +1.30% | $200.20 | $202.80 |
| 2018 | -57.16% | $211.00 | $90.40 |
| 2019 | -28.57% | $96.60 | $69.00 |
| 2020 | +631.34% | $67.00 | $490.00 |
| 2021 | -66.76% | $501.20 | $166.60 |
| 2022 | -36.65% | $176.80 | $112.00 |
| 2023 | -74.07% | $108.00 | $28.00 |
| 2024 | -40.64% | $28.00 | $16.62 |
| 2025 | -11.74% | $16.86 | $14.88 |
Historical annual returns for Seres Therapeutics, Inc.. Data shows year-over-year percentage change in stock price.
Why Use a "What If" Stock Calculator?
Many investors wonder questions such as:
- What if I had invested 5 years ago?
- How does timing affect long-term returns?
- What role does compounding play in stock investments?
A what-if investment calculator answers these questions by turning historical data into practical insights. Rather than focusing on daily price movements, it encourages a long-term perspective, which is especially useful for retirement planning, portfolio comparisons, and financial education.
Key Innovations
- ✓Ecobiotic® drugs
- ✓VOWST™ (first FDA-approved oral microbiome therapeutic)
Business Segments
- TherapeuticsDevelopment of microbiome therapeutics.
How to Interpret the Results
The results shown are based on historical performance and are meant for educational and informational purposes only. They do not account for future market conditions, taxes, transaction fees, or individual investment strategies. Past performance does not guarantee future results, but historical analysis can help investors understand risk, volatility, and growth potential.
For best use:
- Compare multiple time ranges to see how outcomes differ
- Use consistent assumptions across different stocks
- Combine this tool with fundamental research and diversification principles